Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 12, 2024

BUY
$73.27 - $83.09 $70,485 - $79,932
962 Added 4.1%
24,412 $1.98 Million
Q3 2023

Oct 13, 2023

BUY
$73.94 - $80.67 $142,778 - $155,773
1,931 Added 8.97%
23,450 $1.76 Million
Q2 2023

Jul 14, 2023

SELL
$76.01 - $86.7 $36,712 - $41,876
-483 Reduced 2.2%
21,519 $1.66 Million
Q1 2023

Apr 06, 2023

SELL
$77.31 - $88.08 $271,667 - $309,513
-3,514 Reduced 13.77%
22,002 $1.83 Million
Q4 2022

Jan 06, 2023

BUY
$62.32 - $89.47 $41,193 - $59,139
661 Added 2.66%
25,516 $0
Q2 2022

Jul 01, 2022

BUY
$57.72 - $65.01 $1.43 Million - $1.62 Million
24,855 New
24,855 $1.54 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Insight Wealth Strategies, LLC Portfolio

Follow Insight Wealth Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Insight Wealth Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Insight Wealth Strategies, LLC with notifications on news.